accountCongress is considering a $37 billion proposal that would deny pharmaceutical companies from taking tax deductions on direct-to-consumer advertising of prescription drugs.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Congress Mulls Scrapping Tax Break for Pharma Ads
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account